The Feinstein Institute for Medical Research
Manhasset, New York, 11030, United States
NCT Number: NCT01076101
This study enrolled over 400 unaffected sisters of young women diagnosed with SLE. These unaffected sisters are being followed with an annual health questionnaire (CSQ) and blood sample.
Looking for future studies?
Notify Me10 year–45 year
Female
Observational
Manhasset, New York, 11030, United States
Systemic Lupus Erythematosus (SLE) is a chronic autoimmune disease that causes inflammation and is accompanied by the development of autoantibodies. The inflammation caused by SLE may affect the skin, joints, lungs, blood, kidneys and nervous system. The cause of SLE is unknown, but research has indicated that it is caused by a combination of genetic and environmental factors.
Autoimmune diseases often run in families. Close relatives of people with these diseases are at greater risk of developing the same or another autoimmune disease. The study is designed to determine several things: If sisters of people with SLE make the same antibodies that are present in people with SLE, whether or not environmental factors affect the chances of developing these antibodies and if so what these environmental factors may be, if the presence of these antibodies in healthy people leads to increased risk for the development of SLE.
This study enrolled over 400 unaffected sisters of young women diagnosed with SLE. These unaffected sisters are being followed with an annual health questionnaire (CSQ) and blood sample.
Participation is voluntary and participants can stop participating at any time.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Sister Diagnosed with SLE:
Inclusion criteria
Exclusion criteria
If inclusion criteria above are met for the proband, there are no exclusions.
Sister who does not have SLE:
Inclusion criteria
Exclusion criteria
If Sister meets inclusion criteria, there will be no exclusions.
Time frame: 5 years
Time frame: 5 years
Northwell Health
Other
Mapping Autoimmune Phenotypes in Multiplex Families (MADGC 2)
Acronym: SisSLE
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03575156
Autoimmune Diseases, Connective Tissue Diseases
Bordeaux, France
View Trial DetailsNCT01729455
Autoimmune Diseases, Connective Tissue Diseases
Birmingham, Alabama, United States
View Trial DetailsNCT05544448
Acquired Bone Marrow Aplasia, Alopecia
Créteil, Île-de-France Region, France
View Trial DetailsNCT05315739
Autoimmune Diseases, Autonomic Dysfunction
Copenhagen, Denmark
View Trial Details